Sagar Lonial, MD, Discusses Role of Anti-BCMA Therapies

Sagar Lonial, MD, FACP, chair of the Department of Hematology and Medical Oncology at Emory University School of Medicine, sat down with Targeted Oncology to discuss the role of anti-BCMA therapies. He discussed how bispecific t cell engagers play a role in myeloma.

To read the full transcript, visit Targeted Oncology.

Tags: myeloma, bispecific t cell engagers, BCMA